Stemtech (STEK) EBT Growth (1y) (2013 - 2025)
Stemtech (STEK) EBT Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -24.84% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -23.88% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1,578.91% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -342.95% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -267.87% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 62.03% |
| 10 | Stemtech | - | - | 354,677.00 | -273.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -273.77% |
| Sep 30, 2025 | 30.64% |
| Jun 30, 2025 | 62.21% |
| Mar 31, 2025 | -2.68% |
| Dec 31, 2024 | 78.72% |
| Sep 30, 2024 | -16.38% |
| Jun 30, 2024 | -171.28% |
| Mar 31, 2024 | 37.48% |
| Dec 31, 2023 | -317.83% |
| Sep 30, 2023 | -105.79% |
| Jun 30, 2023 | 98.84% |
| Mar 31, 2023 | -346.09% |
| Dec 31, 2022 | 47.40% |
| Sep 30, 2022 | 426.83% |
| Jun 30, 2022 | -3,129.07% |
| Mar 31, 2022 | -198.84% |
| Nov 30, 2020 | 6.72% |
| May 31, 2020 | 0.27% |
| Feb 29, 2020 | 0.75% |
| Nov 30, 2019 | -3.04% |